Compare Agnico Eagle Mines Ltd (AEM) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agnico Eagle Mines Ltd vs Mesoblast Limited — how do they compare? Agnico Eagle Mines Ltd trades at $184.09 (market cap $92.01B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Agnico Eagle Mines Ltd is far larger — about 41.6× Mesoblast Limited's market cap, and Agnico Eagle Mines Ltd pays a 0.99% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| AEM | MESO | |
|---|---|---|
Market Cap | $92.01B | $2.21B |
Sector | Basic Materials | Technology |
52-Week High | $252.19 | $20.96 |
52-Week Low | $130.23 | $12.88 |
Enterprise Value | $88.85B | $2.21B |
Dividend Yield | 0.99% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agnico Eagle Mines Ltd
Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Read more on AEM →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
